First Midwest Bank Trust Division’s Agile Therapeutics AGRX Stock Holding History

First Midwest Bank Trust Division’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$79K	Sell	80 -88	-52%	-$124K	0.01%	375
2021 Q3	$322K	Sell	168 -7	-4%	-$15.8K	0.05%	304
2021 Q2	$464K	Sell	175 -114	-39%	-$376K	0.06%	273
2021 Q1	$1.2M	Sell	289 -159	-35%	-$859K	0.17%	146
2020 Q4	$2.57M	Sell	448 -26	-5%	-$153K	0.37%	70
2020 Q3	$2.88M	Buy	474 +4	+0.9%	+$22.9K	0.45%	58
2020 Q2	$2.61M	Buy	470 +234	+99%	+$1.22M	0.43%	62
2020 Q1	$877K	Buy	+236	New	+$1.35M	0.16%	147

Other funds holding AGRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Midwest Bank Trust Division's AGRX Position: Q4 2021 in Review

First Midwest Bank Trust Division reduced its Agile Therapeutics (AGRX) stake by 52% in Q4 2021, selling an estimated $124K and leaving 80 shares worth $79K. The position accounts for 0.01% of the portfolio, ranked #375.

First Midwest Bank Trust Division first reported a position in AGRX in Q1 2020 and has held it in 8 quarters since. The position peaked at $2.88M in Q3 2020. 45 funds tracked by Wall St. Rank hold AGRX as of Q4 2021.

First Midwest Bank Trust Division held 80 shares of Agile Therapeutics worth $79K as of Q4 2021.
First Midwest Bank Trust Division sold 88 Agile Therapeutics shares in Q4 2021, an estimated $124K.
Agile Therapeutics made up 0.01% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #375 holding.
First Midwest Bank Trust Division first reported a position in Agile Therapeutics in Q1 2020 and has held it in 8 quarters since.
First Midwest Bank Trust Division's Agile Therapeutics position peaked at $2.88M in Q3 2020.
45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.